Outlook on the Sustained Release Injectables Market to 2026 - Featuring Eli Lilly, AstraZeneca, Ipsen, Novartis, Roche, Sanofi, and More

Source :: PR Newswire. September 24, 2019
Publication Year :: 2019
Abstract: DUBLIN, Sept. 24, 2019 /PRNewswire/ -- The 'Sustained Release Injectables to 2026' report has been added to ResearchAndMarkets.com's offering. Sustained Release Injectables to 2026 is a comprehensive evaluation and analysis [...]

Subjects :: Novartis AG -- Forecasts and trends -- Reports
AstraZeneca PLC -- Forecasts and trends -- Reports
Eli Lilly and Co. -- Forecasts and trends -- Reports
Sanofi S.A. -- Forecasts and trends -- Reports
Aripiprazole -- Reports
Drugs -- Vehicles
Bupivacaine -- Reports
Lanreotide -- Reports
Vincristine -- Reports
Marketing -- Reports
Drug delivery systems -- Reports
Pharmaceutical industry -- Forecasts and trends -- Reports
Somatropin -- Reports
Exenatide -- Reports
Market trend/market analysis
Business
News, opinion and commentary

Tools